Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.
D000328:Adult; D000368:Aged; D001792:Blood Platelets; D001853:Bone Marrow / Q000648:ultrastructure; D001854:Bone Marrow Cells; D002066:Busulfan / Q000627:therapeutic use; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D002903:Chromosomes, Human, 19-20; D002904:Chromosomes, Human, 21-22 and Y; D002906:Chromosomes, Human, 6-12 and X; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007621:Karyotyping; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D014178:Translocation, Genetic
D006454:Hemoglobins; D002066:Busulfan